Regulation and standardization of IPV and IPV combination vaccines

Biologicals

Volumn 34, Issue 2, 2006, Pages 159-161

  Baca Estrada, Maria ^a   Griffiths, Elwyn ^a  

^a HEALTH CANADA   (Canada)

Author keywords

D antigen; ELISA; Immunogenicity assay

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; CHICK; DRUG MANUFACTURE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MONKEY; PRIORITY JOURNAL; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; POLIOVIRUS VACCINE, INACTIVATED; RATS; VACCINES, COMBINED; WORLD HEALTH ORGANIZATION;

POLIOVIRUS;

EID: 33646806103     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2006.03.001     Document Type: Article

References (14)

1. Beale A.J., and Mason P.J. The measurement of the D-antigen in poliovirus preparations. J Hyg Camb 60 (1962) 113-121
2. Ferguson M., Wood D., and Minor P.D. Antigenic structure of poliovirus in inactivated vaccines. J Gen Virol 74 (1993) 685-690
3. Rezapkin G., Martin J., and Chumakov K. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method. Biologicals 33 (2005) 29-39
4. Wood D.J., and Heath A.B. A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines. Biologicals 23 (1995) 301-311
5. In vivo assay of poliomyelitis vaccine (inactivated). European pharmacopoeia 2.7.20.
6. Recommendations for the production and control of poliomyelitis vaccine (inactivated). Annex 2, Word Health Organization. World Health Organ Tech Rep Ser 910 (2002) 32-65
7. Van Steenis G., van Wezel A.L., and Sekhuis V.M. Potency testing of killed polio vaccine in rats. Dev Biol Std 47 (1981) 119-128
8. Wood D.J., Heath A.B., and Sawayer L.A. A WHO collaborative study on assays of the antigenic content of inactivated poliovirus vaccines. Biologicals 23 (1995) 83-94
9. Morgeaux S., Milne C., and Daas A. Feasibility study to develop a common in vitro D antigen assay for inactivated poliomyelitis vaccines. Pharmeuropa Bio 1 (2005) 19-25
10. Rezapkin G., Dragunsky E., and Chumakov K. Improved ELISA test for determination of potency of inactivated poliovirus vaccine (IPV). Biologicals 33 (2005) 17-27
11. Kersten G., Hazendonk T., and Beuvery C. Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains. Vaccine 17 (1999) 2059-2066
12. Doi Y., Abe S., Yamamoto H., Horie H., Ohyama H., Satoh K., et al. Progress with inactivated poliovirus vaccines derived from the Sabin strains. Dev Biol 105 (2001) 163-169
13. Dragunsky E.M., Ivanov A.P., Wells V.R., Ivshina A.V., Rezapkin G.V., Abe S., et al. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy. J Infect Dis 90 (2004) 1404-1412
14. Wood D.J., Heath A.B., Kersten G.F.A., Hazendonk T., Lantinga M., and Beuvery E.C. A new WHO International Reference reagent for use in potency assays of inactivated poliomyelitis vaccine. Biologicals 25 (1997) 59-64